-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medicine Net, June 15 news.
Currently, there are 14 inter-provincial alliances for centralized drug procurement
.
Including Sanming Alliance, Shaanxi Leading 11 Provinces Alliance, Shaanxi Leading Anticancer Drugs 14 Provinces (Regions) Alliance, Chongqing Leading 5 Provinces Alliance, Sichuan Leading 6 Provinces and 2 District Alliances, "Shanghai, Jiangsu, Zhejiang, Anhui and Fujian" Four Provinces and One City Alliance, Guangdong Leading 10-provincial alliance, Beijing-Tianjin-Hebei “3% 20N” alliance, Xinjiang “2% 20N” alliance, Heilongjiang leading the alliance of eight provinces and two regions, Chongqing leading the alliance of common medicines in 8 provinces and regions, Chongqing leading the alliance of shortage medicines in 9 provinces and regions, Guangdong Take the lead in the 16 provinces and regions alliance and the Ganshan-Shaanxi alliance
.
In addition, the Yangtze River Delta Alliance is also brewing
.
Currently, there are 14 inter-provincial alliances for centralized drug procurement
.
Including Sanming Alliance, Shaanxi Leading 11 Provinces Alliance, Shaanxi Leading Anticancer Drugs 14 Provinces (Regions) Alliance, Chongqing Leading 5 Provinces Alliance, Sichuan Leading 6 Provinces and 2 District Alliances, "Shanghai, Jiangsu, Zhejiang, Anhui and Fujian" Four Provinces and One City Alliance, Guangdong Leading 10-provincial alliance, Beijing-Tianjin-Hebei “3% 20N” alliance, Xinjiang “2% 20N” alliance, Heilongjiang leading the alliance of eight provinces and two regions, Chongqing leading the alliance of common medicines in 8 provinces and regions, Chongqing leading the alliance of shortage medicines in 9 provinces and regions, Guangdong Take the lead in the 16 provinces and regions alliance and the Ganshan-Shaanxi alliance
.
In addition, the Yangtze River Delta Alliance is also brewing
.
On June 9, Gansu Pharmaceutical Consumables Purchasing Network issued a notice to issue the "Gansu-Shaanxi Alliance 2021 Drug Centralized Procurement Work Implementation Plan"
.
.
It is clearly initiated by the Gansu Provincial Medical Insurance Bureau and jointly with the Shaanxi Provincial Medical Insurance Bureau to form an alliance (hereinafter referred to as the "Gansu-Shaanxi Alliance") on behalf of the two provinces' medical institutions to carry out the centralized procurement of drugs in 2021
.
.
Scope of medical institutions: All public medical institutions (including military medical institutions, the same below) in the alliance provinces should participate, and medical insurance designated social medical institutions shall be implemented in accordance with the requirements of designated agreement management
.
.
Scope of procurement of drugs: priority is given to the selection of chemical drugs in the medical insurance catalog with high purchase amount, mature clinical use, strong substitutability, and sufficient market competition.
Among them, the same generic drug has been marketed in China or passed the consistency evaluation.
Generic drugs (reference preparations) are not included in this batch of centralized procurement
.
Among them, the same generic drug has been marketed in China or passed the consistency evaluation.
Generic drugs (reference preparations) are not included in this batch of centralized procurement
.
Scope of reporting companies: Except for companies whose medical prices and recruitment credit ratings are "serious" and above
.
Enterprises that have been linked to the provincial drug procurement platforms of Gansu and Shaanxi provinces that fail to declare their online qualifications will be cancelled; those that have not been linked to the provincial drug procurement platforms of Gansu and Shaanxi provinces that have failed to declare will not be accepted in principle within 2 years It participated in the centralized procurement of medicines in the two provinces of Gansu and Shaanxi or applied for the Sunshine website
.
.
Enterprises that have been linked to the provincial drug procurement platforms of Gansu and Shaanxi provinces that fail to declare their online qualifications will be cancelled; those that have not been linked to the provincial drug procurement platforms of Gansu and Shaanxi provinces that have failed to declare will not be accepted in principle within 2 years It participated in the centralized procurement of medicines in the two provinces of Gansu and Shaanxi or applied for the Sunshine website
.
Purchase volume and purchase cycle
The procurement base is determined by the two provinces.
The agreed procurement volume is determined not to be less than 50% of the procurement base.
Drugs such as antibacterial drugs and medical insurance-restricted medications shall be appropriately reduced in proportion to the agreed procurement volume
.
The procurement cycle of the selected drugs is in principle one year, which can be extended for one year as the case may be.
The procurement agreement is signed every year
.
The agreed procurement volume is determined not to be less than 50% of the procurement base.
Drugs such as antibacterial drugs and medical insurance-restricted medications shall be appropriately reduced in proportion to the agreed procurement volume
.
The procurement cycle of the selected drugs is in principle one year, which can be extended for one year as the case may be.
The procurement agreement is signed every year
.
The medical institution shall complete the agreed purchase amount during the purchase agreement period.
For the part that exceeds the agreed purchase amount during the purchase agreement period, the enterprise shall still supply the selected price until the end of the purchase period
.
During the procurement cycle, if the centralized procurement of drugs is included in the national procurement catalog, the results of the national procurement will be implemented after the expiration of the procurement agreement
.
For the part that exceeds the agreed purchase amount during the purchase agreement period, the enterprise shall still supply the selected price until the end of the purchase period
.
During the procurement cycle, if the centralized procurement of drugs is included in the national procurement catalog, the results of the national procurement will be implemented after the expiration of the procurement agreement
.
Priority equipment and use
Medical institutions shall include the selected drugs in the drug catalogue of medical institutions, and shall not influence the rational use and supply guarantee of the selected drugs on the grounds of review by the Pharmaceutical Affairs Committee, cost control, proportion of drugs, and specifications and quantities of drugs used by medical institutions
.
.
Medical institutions should give priority to the use of selected drugs, strictly implement the selected prices, and ensure that the agreed purchase volume is completed
.
In addition to the agreed purchase quantity, each medical institution may, according to its own conditions and relevant regulations, purchase an appropriate amount of non-selected drugs of the same variety at a suitable price.
If the price is higher than the price of the selected drug, the purchase quantity shall not exceed the selected drug purchase quantity in principle
.
.
In addition to the agreed purchase quantity, each medical institution may, according to its own conditions and relevant regulations, purchase an appropriate amount of non-selected drugs of the same variety at a suitable price.
If the price is higher than the price of the selected drug, the purchase quantity shall not exceed the selected drug purchase quantity in principle
.
Implement the fund prepayment policy: on the basis of the total budget of the medical insurance fund, the medical insurance department shall prepay the fund at no less than 30% of the agreed purchase amount of the medical institution, as the working capital of the medical institution to pay the enterprise for the purchase of drugs , after the expiry of the purchase agreement , The medical institution returns the prepaid fund to the medical insurance department
.
.
Improve medical insurance payment policy: Explore the establishment of a coordination mechanism between medical insurance payment standards and centralized procurement prices
.
The selected drugs use the selected price as the medical insurance payment standard, and the payment standard of the non-selected drugs with the same generic name is gradually adjusted to the selected price
.
.
The selected drugs use the selected price as the medical insurance payment standard, and the payment standard of the non-selected drugs with the same generic name is gradually adjusted to the selected price
.
Implementation of the remaining balance retention policy: All provinces should do a good job in retaining the remaining balance of medical insurance funds for the centralized procurement of drugs in accordance with the relevant policies of the province, fully mobilize the enthusiasm of medical institutions and medical staff, and promote the implementation of the selected results
.
.
Medicine Net, June 15 news.
Currently, there are 14 inter-provincial alliances for centralized drug procurement
.
Including Sanming Alliance, Shaanxi Leading 11 Provinces Alliance, Shaanxi Leading Anticancer Drugs 14 Provinces (Regions) Alliance, Chongqing Leading 5 Provinces Alliance, Sichuan Leading 6 Provinces and 2 District Alliances, "Shanghai, Jiangsu, Zhejiang, Anhui and Fujian" Four Provinces and One City Alliance, Guangdong Leading 10-provincial alliance, Beijing-Tianjin-Hebei “3% 20N” alliance, Xinjiang “2% 20N” alliance, Heilongjiang leading the alliance of eight provinces and two regions, Chongqing leading the alliance of common medicines in 8 provinces and regions, Chongqing leading the alliance of shortage medicines in 9 provinces and regions, Guangdong Take the lead in the 16 provinces and regions alliance and the Ganshan-Shaanxi alliance
.
In addition, the Yangtze River Delta Alliance is also brewing
.
Currently, there are 14 inter-provincial alliances for centralized drug procurement
.
Including Sanming Alliance, Shaanxi Leading 11 Provinces Alliance, Shaanxi Leading Anticancer Drugs 14 Provinces (Regions) Alliance, Chongqing Leading 5 Provinces Alliance, Sichuan Leading 6 Provinces and 2 District Alliances, "Shanghai, Jiangsu, Zhejiang, Anhui and Fujian" Four Provinces and One City Alliance, Guangdong Leading 10-provincial alliance, Beijing-Tianjin-Hebei “3% 20N” alliance, Xinjiang “2% 20N” alliance, Heilongjiang leading the alliance of eight provinces and two regions, Chongqing leading the alliance of common medicines in 8 provinces and regions, Chongqing leading the alliance of shortage medicines in 9 provinces and regions, Guangdong Take the lead in the 16 provinces and regions alliance and the Ganshan-Shaanxi alliance
.
In addition, the Yangtze River Delta Alliance is also brewing
.
On June 9, Gansu Pharmaceutical Consumables Purchasing Network issued a notice to issue the "Gansu-Shaanxi Alliance 2021 Drug Centralized Procurement Work Implementation Plan"
.
.
It is clearly initiated by the Gansu Provincial Medical Insurance Bureau and jointly with the Shaanxi Provincial Medical Insurance Bureau to form an alliance (hereinafter referred to as the "Gansu-Shaanxi Alliance") on behalf of the two provinces' medical institutions to carry out the centralized procurement of drugs in 2021
.
.
Scope of medical institutions: All public medical institutions (including military medical institutions, the same below) in the alliance provinces should participate, and medical insurance designated social medical institutions shall be implemented in accordance with the requirements of designated agreement management
.
.
Scope of procurement of drugs: priority is given to the selection of chemical drugs in the medical insurance catalog with high purchase amount, mature clinical use, strong substitutability, and sufficient market competition.
Among them, the same generic drug has been marketed in China or passed the consistency evaluation.
Generic drugs (reference preparations) are not included in this batch of centralized procurement
.
Among them, the same generic drug has been marketed in China or passed the consistency evaluation.
Generic drugs (reference preparations) are not included in this batch of centralized procurement
.
Scope of reporting companies: Except for companies whose medical prices and recruitment credit ratings are "serious" and above
.
Enterprises that have been linked to the provincial drug procurement platforms of Gansu and Shaanxi provinces that fail to declare their online qualifications will be cancelled; those that have not been linked to the provincial drug procurement platforms of Gansu and Shaanxi provinces that have failed to declare will not be accepted in principle within 2 years It participated in the centralized procurement of medicines in the two provinces of Gansu and Shaanxi or applied for the Sunshine website
.
.
Enterprises that have been linked to the provincial drug procurement platforms of Gansu and Shaanxi provinces that fail to declare their online qualifications will be cancelled; those that have not been linked to the provincial drug procurement platforms of Gansu and Shaanxi provinces that have failed to declare will not be accepted in principle within 2 years It participated in the centralized procurement of medicines in the two provinces of Gansu and Shaanxi or applied for the Sunshine website
.
Purchase volume and purchase cycle
The procurement base is determined by the two provinces.
The agreed procurement volume is determined not to be less than 50% of the procurement base.
Drugs such as antibacterial drugs and medical insurance-restricted medications shall be appropriately reduced in proportion to the agreed procurement volume
.
The procurement cycle of the selected drugs is in principle one year, which can be extended for one year as the case may be.
The procurement agreement is signed every year
.
The agreed procurement volume is determined not to be less than 50% of the procurement base.
Drugs such as antibacterial drugs and medical insurance-restricted medications shall be appropriately reduced in proportion to the agreed procurement volume
.
The procurement cycle of the selected drugs is in principle one year, which can be extended for one year as the case may be.
The procurement agreement is signed every year
.
The medical institution shall complete the agreed purchase amount during the purchase agreement period.
For the part that exceeds the agreed purchase amount during the purchase agreement period, the enterprise shall still supply the selected price until the end of the purchase period
.
During the procurement cycle, if the centralized procurement of drugs is included in the national procurement catalog, the results of the national procurement will be implemented after the expiration of the procurement agreement
.
For the part that exceeds the agreed purchase amount during the purchase agreement period, the enterprise shall still supply the selected price until the end of the purchase period
.
During the procurement cycle, if the centralized procurement of drugs is included in the national procurement catalog, the results of the national procurement will be implemented after the expiration of the procurement agreement
.
Priority equipment and use
Medical institutions shall include the selected drugs in the drug catalogue of medical institutions, and shall not influence the rational use and supply guarantee of the selected drugs on the grounds of review by the Pharmaceutical Affairs Committee, cost control, proportion of drugs, and specifications and quantities of drugs used by medical institutions
.
.
Medical institutions should give priority to the use of selected drugs, strictly implement the selected prices, and ensure that the agreed purchase volume is completed
.
In addition to the agreed purchase quantity, each medical institution may, according to its own conditions and relevant regulations, purchase an appropriate amount of non-selected drugs of the same variety at a suitable price.
If the price is higher than the price of the selected drug, the purchase quantity shall not exceed the selected drug purchase quantity in principle
.
.
In addition to the agreed purchase quantity, each medical institution may, according to its own conditions and relevant regulations, purchase an appropriate amount of non-selected drugs of the same variety at a suitable price.
If the price is higher than the price of the selected drug, the purchase quantity shall not exceed the selected drug purchase quantity in principle
.
Implement the fund prepayment policy: on the basis of the total budget of the medical insurance fund, the medical insurance department shall prepay the fund at no less than 30% of the agreed purchase amount of the medical institution, as the working capital of the medical institution to pay the enterprise for the purchase of drugs , after the expiry of the purchase agreement , The medical institution returns the prepaid fund to the medical insurance department
.
.
Improve medical insurance payment policy: Explore the establishment of a coordination mechanism between medical insurance payment standards and centralized procurement prices
.
The selected drugs use the selected price as the medical insurance payment standard, and the payment standard of the non-selected drugs with the same generic name is gradually adjusted to the selected price
.
.
The selected drugs use the selected price as the medical insurance payment standard, and the payment standard of the non-selected drugs with the same generic name is gradually adjusted to the selected price
.
Implementation of the remaining balance retention policy: All provinces should do a good job in retaining the remaining balance of medical insurance funds for the centralized procurement of drugs in accordance with the relevant policies of the province, fully mobilize the enthusiasm of medical institutions and medical staff, and promote the implementation of the selected results
.
.
Medicine Net, June 15 news.
Currently, there are 14 inter-provincial alliances for centralized drug procurement
.
Including Sanming Alliance, Shaanxi Leading 11 Provinces Alliance, Shaanxi Leading Anticancer Drugs 14 Provinces (Regions) Alliance, Chongqing Leading 5 Provinces Alliance, Sichuan Leading 6 Provinces and 2 District Alliances, "Shanghai, Jiangsu, Zhejiang, Anhui and Fujian" Four Provinces and One City Alliance, Guangdong Leading 10-provincial alliance, Beijing-Tianjin-Hebei “3% 20N” alliance, Xinjiang “2% 20N” alliance, Heilongjiang leading the alliance of eight provinces and two regions, Chongqing leading the alliance of common medicines in 8 provinces and regions, Chongqing leading the alliance of shortage medicines in 9 provinces and regions, Guangdong Take the lead in the 16 provinces and regions alliance and the Ganshan-Shaanxi alliance
.
In addition, the Yangtze River Delta Alliance is also brewing
.
Currently, there are 14 inter-provincial alliances for centralized drug procurement
.
Including Sanming Alliance, Shaanxi Leading 11 Provinces Alliance, Shaanxi Leading Anticancer Drugs 14 Provinces (Regions) Alliance, Chongqing Leading 5 Provinces Alliance, Sichuan Leading 6 Provinces and 2 District Alliances, "Shanghai, Jiangsu, Zhejiang, Anhui and Fujian" Four Provinces and One City Alliance, Guangdong Leading 10-provincial alliance, Beijing-Tianjin-Hebei “3% 20N” alliance, Xinjiang “2% 20N” alliance, Heilongjiang leading the alliance of eight provinces and two regions, Chongqing leading the alliance of common medicines in 8 provinces and regions, Chongqing leading the alliance of shortage medicines in 9 provinces and regions, Guangdong Take the lead in the 16 provinces and regions alliance and the Ganshan-Shaanxi alliance
.
In addition, the Yangtze River Delta Alliance is also brewing
.
On June 9, Gansu Pharmaceutical Consumables Purchasing Network issued a notice to issue the "Gansu-Shaanxi Alliance 2021 Drug Centralized Procurement Work Implementation Plan"
.
.
It is clearly initiated by the Gansu Provincial Medical Insurance Bureau and jointly with the Shaanxi Provincial Medical Insurance Bureau to form an alliance (hereinafter referred to as the "Gansu-Shaanxi Alliance") on behalf of the two provinces' medical institutions to carry out the centralized procurement of drugs in 2021
.
.
Scope of medical institutions: All public medical institutions (including military medical institutions, the same below) in the alliance provinces should participate, and medical insurance designated social medical institutions shall be implemented in accordance with the requirements of designated agreement management
.
.
Scope of procurement of drugs: priority is given to the selection of chemical drugs in the medical insurance catalog with high purchase amount, mature clinical use, strong substitutability, and sufficient market competition.
Among them, the same generic drug has been marketed in China or passed the consistency evaluation.
Generic drugs (reference preparations) are not included in this batch of centralized procurement
.
Among them, the same generic drug has been marketed in China or passed the consistency evaluation.
Generic drugs (reference preparations) are not included in this batch of centralized procurement
.
Scope of reporting companies: Except for companies whose medical prices and recruitment credit ratings are "serious" and above
.
Enterprises that have been linked to the provincial drug procurement platforms of Gansu and Shaanxi provinces that fail to declare their online qualifications will be cancelled; those that have not been linked to the provincial drug procurement platforms of Gansu and Shaanxi provinces that have failed to declare will not be accepted in principle within 2 years It participated in the centralized procurement of medicines in the two provinces of Gansu and Shaanxi or applied for the Sunshine website
.
Medicine, medicine, medicine.
Enterprises that have been linked to the provincial drug procurement platforms of Gansu and Shaanxi provinces that fail to declare their online qualifications will be cancelled; those that have not been linked to the provincial drug procurement platforms of Gansu and Shaanxi provinces that have failed to declare will not be accepted in principle within 2 years It participated in the centralized procurement of medicines in the two provinces of Gansu and Shaanxi or applied for the Sunshine website
.
Purchase volume and purchase cycle
Purchase volume and purchase cycle The procurement base is determined by the two provinces.
The agreed procurement volume is determined not to be less than 50% of the procurement base.
Drugs such as antibacterial drugs and medical insurance-restricted medications shall be appropriately reduced in proportion to the agreed procurement volume
.
The procurement cycle of the selected drugs is in principle one year, which can be extended for one year as the case may be.
The procurement agreement is signed every year
.
The agreed procurement volume is determined not to be less than 50% of the procurement base.
Drugs such as antibacterial drugs and medical insurance-restricted medications shall be appropriately reduced in proportion to the agreed procurement volume
.
The procurement cycle of the selected drugs is in principle one year, which can be extended for one year as the case may be.
The procurement agreement is signed every year
.
The medical institution shall complete the agreed purchase amount during the purchase agreement period.
For the part that exceeds the agreed purchase amount during the purchase agreement period, the enterprise shall still supply the selected price until the end of the purchase period
.
During the procurement cycle, if the centralized procurement of drugs is included in the national procurement catalog, the results of the national procurement will be implemented after the expiration of the procurement agreement
.
For the part that exceeds the agreed purchase amount during the purchase agreement period, the enterprise shall still supply the selected price until the end of the purchase period
.
During the procurement cycle, if the centralized procurement of drugs is included in the national procurement catalog, the results of the national procurement will be implemented after the expiration of the procurement agreement
.
Priority equipment and use
Priority equipment and use Medical institutions shall include the selected drugs in the drug catalogue of medical institutions, and shall not influence the rational use and supply guarantee of the selected drugs on the grounds of review by the Pharmaceutical Affairs Committee, cost control, proportion of drugs, and specifications and quantities of drugs used by medical institutions
.
Medicine Medicine Medicine.
Medical institutions should give priority to the use of selected drugs, strictly implement the selected prices, and ensure that the agreed purchase volume is completed
.
In addition to the agreed purchase quantity, each medical institution may, according to its own conditions and relevant regulations, purchase an appropriate amount of non-selected drugs of the same variety at a suitable price.
If the price is higher than the price of the selected drug, the purchase quantity shall not exceed the selected drug purchase quantity in principle
.
.
In addition to the agreed purchase quantity, each medical institution may, according to its own conditions and relevant regulations, purchase an appropriate amount of non-selected drugs of the same variety at a suitable price.
If the price is higher than the price of the selected drug, the purchase quantity shall not exceed the selected drug purchase quantity in principle
.
Implement the fund prepayment policy: on the basis of the total budget of the medical insurance fund, the medical insurance department shall prepay the fund at no less than 30% of the agreed purchase amount of the medical institution, as the working capital of the medical institution to pay the enterprise for the purchase of drugs , after the expiry of the purchase agreement , The medical institution returns the prepaid fund to the medical insurance department
.
Enterprise business enterprise procurement procurement procurement.
Improve medical insurance payment policy: Explore the establishment of a coordination mechanism between medical insurance payment standards and centralized procurement prices
.
The selected drugs use the selected price as the medical insurance payment standard, and the payment standard of the non-selected drugs with the same generic name is gradually adjusted to the selected price
.
Standard Standard Standard.
The selected drugs use the selected price as the medical insurance payment standard, and the payment standard of the non-selected drugs with the same generic name is gradually adjusted to the selected price
.
Implementation of the remaining balance retention policy: All provinces should do a good job in retaining the remaining balance of medical insurance funds for the centralized procurement of drugs in accordance with the relevant policies of the province, fully mobilize the enthusiasm of medical institutions and medical staff, and promote the implementation of the selected results
.
.
